Hypothermia for newborns with hypoxic-ischemic encephalopathy

Area of Science:

• Neonatal Medicine
• Pediatric Neurology
• Critical Care

Background:

• Hypoxic-ischemic encephalopathy (HIE) is a serious condition in newborns.
• Therapeutic hypothermia is a recognized treatment for moderate-to-severe HIE.
• Evidence supports its use in infants ≥36 weeks gestational age (GA).

Purpose of the Study:

• To outline the current recommendations for therapeutic hypothermia in HIE.
• To provide guidance on its application in specific gestational age groups.
• To detail optimal cooling parameters and adjunctive treatments.

Main Methods:

• Review of existing evidence and clinical guidelines.
• Focus on gestational age criteria for hypothermia initiation.
• Emphasis on temperature monitoring and management.

Main Results:

• Therapeutic hypothermia is standard for infants ≥36 weeks GA with moderate-to-severe HIE.
• Consideration for infants at 35 weeks GA if criteria are met; not recommended for <35 weeks GA.
• Optimal core temperature is 33-34°C for 72 hours, followed by 6-12 hours rewarming.

Conclusions:

• Therapeutic hypothermia, when initiated promptly and managed optimally, is crucial for HIE.
• Adjunctive treatments include seizure management and metabolic/gas exchange control.
• Neuroimaging (MRI) and multidisciplinary follow-up are vital for assessing outcomes.